AI-Based Prediction of HCC Recurrence Patterns After Resection (APAR) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

AI-Based Prediction of HCC Recurrence Patterns After Resection (APAR) — Stella

Recruiting

Back to Hepatecellular Carcinoma trials

Trial locations(1 site)

China

Tongji Hospital, Wuhan, Hubei

Key details

Sponsor

Tongji Hospital

Enrollment target

~353 participants

Started

June 2025

Primary completion

June 2026

Age range

18 Years – 75 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov